MARDEE BAXLEY: Open Payments
NPI 1063058972 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$698 in 34 payments from 13 companies in 2025. Trend: 2023 $459 · 2024 $257 · 2025 $698
Food & beverage: $698
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $138 |
| AstraZeneca Pharmaceuticals LP | 5 | $95 |
| Ardelyx, Inc. | 4 | $88 |
| Fresenius USA Marketing, Inc. | 4 | $81 |
| Amgen Inc. | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| ANI Pharmaceuticals, Inc. | 2 | $42 |
| Vifor Pharma, Inc. | 2 | $41 |
| Calliditas Therapeutics US Inc. | 1 | $31 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
Products named: JYNARQUE, FARXIGA, IBSRELA, VELPHORO, Kerendia, KRYSTEXXA, PURIFIED CORTROPHIN GEL, Veltassa.
Industry payments across NC — which companies pay providers there.
